Ind-Swift Laboratories Limited

₹336.95As of Sun 8 Nov 2026, 12:00 UTC
NSE:INDSWFTLABHealthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR 22.48%
Div yield —
ROE 6.13%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.88
PE TTM 34.63
TSR TTM 228.06%
Mkt cap ₹29.30B
ROIC 5.96%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹355
5.28%
(32.17%)
Hold 11|4|1|1|12
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
3.89
3.82
3.99
3.94
15.81%
6.28%
7.66%
(0.14%)
Revenue₹B
1.759
1.733
1.824
1.922
0.51%
1.63%
8.17%
14.72%
Peers (US$320.6M)
Cap (US$)
PE
286.1M
—
Capital
TTM
5Y
10Y
Leveragex
7.190
0.234
0.233
EBIT/Intx
1.354
1.086
0.940
Own earn%
(70.84)
(45.13)
(41.70)
Sh yield%
28.74
31.48
34.42
Owners
Insiders/Inst%
2.48
82.85
Short interest%
1.71
SBC / revenue%
1.14
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
23
Op margin range%
28–32
$1 testx
0.0
Incr. ROIC%
9